{"id":90667,"title":"Bramante Biologics - American drug manufacturing","tagline":"Manufacturing pharmaceutical drugs faster and in the USA","body":"We manufacture pharmaceutical drugs faster than current methods and in the USA. We are building microfactories that can handle the upcoming wave of AI-designed drugs and safeguard against biothreats.\n\n[Launch Video](https://www.youtube.com/watch?v=W_lJOs7k7nI)\n\n### **The Problem**\n\nAmerica is at risk of ceding leadership in advanced biomanufacturing to China.\n\n* **Drug manufacturing is moving to China;** 79% of US biotech and pharma companies already have at least one contract with a Chinese firm, _primarily because they are faster._\n* **China is investing billions in biotech**; one third of new compounds licensed by US pharma are now _discovered and manufactured_ in China, up from almost none five years ago.\n* **Over-reliance on foreign biomanufacturing is a national-security risk;** agile, on-shore manufacturing is critical to protect our nation against future biothreats.\n\n### **Our Solution**\n\nA contract development and manufacturing organization (CDMO) for advanced drugs, rebuilt from the ground up to address the future of America’s biomanufacturing needs.\n\n* **Faster biomanufacturing**; Our platform leverages advanced methods to accelerate production timelines and de-risk scale-up.\n* **Modular container factories**; our form factor is a standard shipping container that can be brought up to operation in roughly two weeks and shipped where it is needed.\n* **Supply-chain independence;** by vertically integrating and manufacturing critical equipment in-house, we secure production against global disruptions.\n\n### **Why It Matters**\n\n* **Drugs can be developed faster**; shorter production cycles move life-saving drugs from the lab to the clinic up to a year sooner.\n* **More drugs can be developed**; we will be able to manufacture the thousands of low-volume, personalized biologics that will be designed by AI.\n* **Strengthening US autonomy;** rapid-deploy, U.S.-based capacity protects the nation from supply shocks, geopolitical turbulence, and potential bioweapons.\n\n### **Who We Are**\n\nWe love biomanufacturing. Together, we built Protein Evolution, an industrial biotech company that turned plastic waste into new textile fibers. Scott is ex-McKinsey and a Yale mathematician (he loves a good cost model almost as much as he loves America). Mike earned his PhD in Bioengineering from Penn after completing Penn’s M&T program in undergrad (he builds DNA, software, and bioreactors).\n\n### **Our Ask**\n\n**Please reach out** if you work in drug development, work at a CDMO, or have experience working with or at the FDA: [**founders@bramantebio.com**](mailto:founders@bramantebio.com)\n\n**Follow along** on our journey:\n\n* [**www.bramantebio.com**](http://www.bramantebio.com)\n* [**www.linkedin.com/company/bramante-biologics**](http://www.linkedin.com/company/bramante-biologics)\n\n![uploaded image](/media/?type=post&id=90667&key=user_uploads/547597/1ed9b2f2-f6d9-4253-b3b0-f7561d246977)\n\n_Let’s build the infrastructure tomorrow’s medicine deserves, right here at home._","slug":"NaN-bramante-biologics-american-drug-manufacturing","created_at":"2025-05-23T16:36:11.138Z","updated_at":"2026-11-18T06:15:52.350Z","total_vote_count":45,"url":"https://www.ycombinator.com/launches/NaN-bramante-biologics-american-drug-manufacturing","share_image_url":"https://www.ycombinator.com/media/?type=post&id=90667&key=user_uploads/547597/1ed9b2f2-f6d9-4253-b3b0-f7561d246977","company":{"id":30516,"name":"Bramante","slug":"bramante","url":"https://www.bramantebio.com","logo":"https://bookface-images.s3.amazonaws.com/small_logos/d13627b06670d3337bda071d8e7bccb8d6728ffd.png","batch":"Spring 2025","industry":"Industrials","tags":["Biotech","Manufacturing","AI"],"search_path":"https://bookface.ycombinator.com/company/30516"}}